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“Always note and record the unusual…Publish it.”  
William Osler (1)
While contemplating the evolution of medical publishing, 
one might be tempted to think about it in terms of Reca-
pitulation theory. This theory claims that the development 
of an individual animal from embryo to adult resembles 
the stages that that species has undergone in the course 
of its evolution. Therefore, it might be conjectured that the 
stages of scientific production in an individual clinician`s 
career follow similar progression as the history of medical 
publishing. In other words, the first medical articles were 
written in a form that resembled today’s case reports, while 
more complex forms, such as randomized controlled trials 
or reviews and meta-analyses, appeared much later. Simi-
larly, individual clinicians, through their career, climb the 
steep “level-of-evidence“ pyramid; during the first clinical 
steps, they write case reports, striving towards taking part 
in reporting clinical trials, and, later as they grow proficient 
in their field of interest write reviews and meta-analyses. 
Even though case reports are indispensable for medical 
progress since they bring attention to novel entities, in 
the evidence based era of impact factors and citations, 
they are often considered to be less valuable, due to their 
low citation rates (2). However, case reports have not only 
changed and grown more complex in their form, but con-
tinue to report on a wide range of topics other than direct 
clinical experience. Similarly, the role of case reports has 
outgrown its primary purpose. In its beginnings, case re-
ports were intended to identify clinical novelty, afterwards 
authors used them as a means to alert about adverse re-
actions and highlight innovations, while today they play a 
significant role in medical education and help emphasize 
ethical predicaments (3,4).
HISTORICAL PERSPECTIVE
Throughout the history of medicine, case reports have 
played a major role, some of them subsequently becom-
ing highly cited works that often represent cornerstone 
publications in their fields. Hippocrates, the father of mod-
ern medicine, reported his findings in what would today 
be considered anecdotal form (5). Sigmund Freud used 
case reports to describe the cases of his patients, which are 
now considered famous and mark the beginning of psy-
choanalysis. Four weeks after having performed the first 
human heart transplantation on December 3, 1967, Chris-
tian Barnaard published a case report in the South African 
Medical Journal (6). Case reports once again proved to be 
crucial in 1981, when a series of such publications report-
ing unusual infections and neoplasms led to the discovery 
of a new syndrome, AIDS (7-9). A recently published case 
series, which reported on a novel therapeutic option for 
Shiga-toxin producing Escherichia coli – hemolytic-uremic 
syndrome, led to advancement in the treatment protocol 
for refractory cases (10,11). Although this example clear-
ly shows that case reports are still an invaluable means of 
communicating medical novelty, from 1970s the propor-
tion of published cases has steadily declined (2). The 1990s 
saw the re-emergence of case reports. Several eminent 
journals made a turn toward a “case report friendly policy,” 
while editorials and commentaries indicated a rise of inter-
est in case reports (2,12,13). Finally, the 2000s witnessed the 
appearance of first exclusively case report journals (14).
THE CARE GUIDELINES
Recently, a group of eminent experts involved in case re-
port writing and editing have addressed the issue of stan-
dardizing case reports (15). The authors pointed out that 
there were guidelines for other publication types that fa-
cilitated standardization. For example, when publishing 
meta-analyses, authors adhere to PRISMA guidelines, and 
when publishing randomized controlled trials they adhere 
to CONSORT guidelines (16,17). The list goes on and en-
compasses mostly all types of publications and, until re-
cently, did not include international reporting case report 
guidelines. However, in September 2013, CARE (CAse RE-
port) guidelines were presented and published in sev-
eral journals (18).
EDITORIAL508 Croat Med J. 2013;54:507-9
www.cmj.hr
CASE REPORT COMEBACK
Why should we care about case reports? Being on the 
bottom of the pyramid, case reports are often neglected 
by both publishers and readers (perhaps even authors?). 
However, their educational role is often overlooked. They 
present a case of a single individual, a unique patient, the 
kind one has in mind when studying a disease and pro-
jecting symptoms into an imaginary patient; and every 
patient, no matter how “ordinary” his or her problem, has 
something to teach us. In this respect, case reports may be 
one of the ways to recover some of the “lost humanity of 
medicine” (19). Higher level-of-evidence articles are more 
refined and highly scientific, but case reports, due to lack of 
guidelines and difficulties in getting them published often 
demand from the author writing and presentation skills 
that more resemble art than science. Moreover, they rep-
resent an “atavism” seen from the epistemological point of 
view; among the multitude of “conjectures and refutations” 
case reports are “the last resort of inductionism” (20,21).
An analysis of the CMJ’s impact factor (IF) structure for 2003 
(22) showed that case reports indeed contributed the least 
to the IF (relative IF only 0.19, compared to 0.91 for origi-
nal articles and 0.63 for reviews) (22). The biggest contribu-
tion was provided by Editorials and Forum (22). Interest-
ingly, journals with the highest IFs have been using results 
of such citation analyses for years now – in Nature 63% of 
published papers were categorized as non-research items 
(editorials, letters, etc.) and in New England Journal of Medi-
cine 81% items (23). The same paper reports on how cer-
tain papers classified as non-research items by journals ac-
tually contained original research data.
It is clear to CMJ editors, as it obviously is to editors of many 
larger journals with greater influence, that it would be wis-
er to publish reviews, original research, letters, correspon-
dence, than case reports. Therefore, many editors now ask 
authors to restructure case reports (not only case reports, 
even original research!) into Letters to Editors. This way 
the case report gets published, but might get “crippled” in 
the restructuring process. However, they can get citations, 
without influencing the denominator when calculating IF.
Is this really the way we are headed? And are we truly put-
ting IF and journal ranking in the first place, and disregard-
ing potential benefits and contribution a case report or 
a full research-article can give to scientific community? 
Though we also are struggling to survive in a commu-
nity where IF has a divine status, and its oscillations 
directly affect the life of a journal and its editors, we sup-
port the “case report comeback.” In a constant struggle to 
survive and increase/maintain our IF, we will not forget that 
we are a small journal striving toward quality and excel-
lence before anything else (including bibliometric param-
eters!). A good article will always get published – even if it 
might increase our denominator. As stated in our Guide-
lines for Authors, case reports still have a low priority in the 
CMJ. However, this does not mean they cannot get pub-
lished. Hereby, we encourage our authors to read and ap-
ply new CARE Guidelines – they can help your case report 
get included into the “who CAREs if it increases the de-
nominator” category.
We invite you to read our three new case reports (24-26) 
and dare you to cite them!
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